Kintara Therapeutics, Inc

Kintara Therapeutics, Inc Our Fight Against Cancer: Kintara is dedicated to the development of novel cancer therapies

Safe Harbor Statement

Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995, including statements regarding the status of the Company's clinical trials and the GBM AGILE study. Any forward-looking statements contained herein are based on current

expectations but are subject to a number of risks and uncertainties. The factors that could cause actual future results to differ materially from current expectations include, but are not limited to, risks and uncertainties relating to the impact of the COVID-19 pandemic on the Company's operations and clinical trials; the Company's ability to develop, market and sell products based on its technology; the expected benefits and efficacy of the Company's products and technology; the availability of substantial additional funding for the Company to continue its operations and to conduct research and development, clinical studies and future product commercialization; and the Company's business, research, product development, regulatory approval, marketing and distribution plans and strategies. These and other factors are identified and described in more detail in the Company's filings with the SEC, including the Company's Annual Report on Form 10-K for the year ended June 30, 2020, the Company's Quarterly Reports on Form 10-Q, and the Company's Current Reports on Form 8-K.

Seeking relief for cutaneous lesions from your metastatic breast cancer?Consider enrolling in the KTI-21-01 study.Are yo...
11/18/2024

Seeking relief for cutaneous lesions from your metastatic breast cancer?

Consider enrolling in the KTI-21-01 study.

Are you or someone you love living with metastatic breast cancer that has spread to the skin? A clinical research trial is testing a new investigational treatment called REM-001 Therapy, and we are looking for participants with cutaneous metastatic breast cancer (CMBC) that is refractory or not eligible for radiotherapy or surgery. Other study requirements must be met for eligibility.

REM-001 is a light-activated drug used in a treatment called photodynamic therapy. It targets cancer cells by using a special laser light directed at the skin lesions, to activate the drug, which then works to destroy the cancer cells. This research study is looking to determine if this investigational treatment may help people with CMBC, as well as the safety of the treatment.

Take the First Step Today
Your participation could help lead to new and better treatments for metastatic breast cancer. Help make a difference in the fight against cancer!

To learn more about this study, contact our clinical team at:
Kintara Therapeutics, Inc.
phone: +1-604-629-5989
https://www.kintara.com/clinical-trials
https://ea.medasystems.com/intake/kintara

Visit https://clinicaltrials.gov/study/NCT05374915 to find more information about the study and locations currently enrolling patients.

UCSF Brain Tumor Center: Glioblastoma is a highly malignant brain tumor that arises from astrocytes, the supportive cell...
03/29/2022

UCSF Brain Tumor Center: Glioblastoma is a highly malignant brain tumor that arises from astrocytes, the supportive cells in the nervous system. https://buff.ly/3LlIcun

Glioblastomas are often very aggressive and grow into surrounding brain tissue. https://buff.ly/3ikG8aJ
03/22/2022

Glioblastomas are often very aggressive and grow into surrounding brain tissue. https://buff.ly/3ikG8aJ

Kintara Therapeutics to Present at the Maxim Group 2022 Virtual Growth Conference https://buff.ly/36FvI1G ...
03/22/2022

Kintara Therapeutics to Present at the Maxim Group 2022 Virtual Growth Conference https://buff.ly/36FvI1G $KTRA

Kintara Therapeutics Announces Data Presentation at the 2022 American Association for Cancer Research Annual Meeting htt...
03/15/2022

Kintara Therapeutics Announces Data Presentation at the 2022 American Association for Cancer Research Annual Meeting https://buff.ly/3KCFhx0 $KTRA

Address

San Diego, CA
San Diego, CA

Website

Alerts

Be the first to know and let us send you an email when Kintara Therapeutics, Inc posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Kintara Therapeutics, Inc:

Shortcuts

Featured

Share

Category